Seqalis Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 14


  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $791K

Seqalis General Information


Provider of laboratory testing, scientific advisory and research and development services. The company offers immuno-oncology, cytogenomics, histopathology, DNA and RNA sequencing, digital PCR, paternity testing and biobanking for anatomical pathology, cytogenetics and molecular biology fields.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Primary Office
  • 25 avenue Georges Lemaitre
  • 6041 Gosselies
  • Belgium
+32 071 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seqalis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - General 01-Jan-2007 $791K 00000 Completed Generating Revenue
To view Seqalis’s complete valuation and funding history, request access »

Seqalis Executive Team (2)

Name Title Board Seat Contact Info
Jean-Luc Henrioul Chief Operating Officer
Jean-Francois Ghidetti Executive Director
To view Seqalis’s complete executive team members history, request access »

Seqalis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seqalis Investments (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BloomX 02-Feb-2023 0000 00000 000 Machinery (B2B)
OncoDNA 09-Aug-2021 00000 0000 0000 Biotechnology
OncoDNA 01-Sep-2016 00000 0000 00.000 Biotechnology
OncoDNA 01-Dec-2012 00000 0000 00.000 Biotechnology
DNAVision 29-Apr-2006 Early Stage VC 000 Other Healthcare Services
To view Seqalis’s complete investments history, request access »